CONSOLIDATED URANIUM INC (CUR.CA) Forecast, Price Target & Analyst Ratings

TSX-V:CURCA21024C1014

Current stock price

1.93 CAD
+0.05 (+2.66%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CONSOLIDATED URANIUM INC (CUR.CA).

Forecast Snapshot

Consensus Price Target

Price Target
CA$5.10
+ 164.25% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
N/A

ChartMill Buy Consensus

Rating
84.00%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
CA$5.10
Upside
+ 164.25%
From current price of CA$1.93 to mean target of CA$5.10, Based on 10 analyst forecasts
Low
CA$5.05
Median
CA$5.10
High
CA$5.25

Price Target Revisions

1 Month
25.00%
3 Months
25.00%

Price Target Summary

10 Wall Street analysts provided a forecast for the next 12 months for CUR.CA. The average price target is 5.1 CAD. This implies a price increase of 164.25% is expected in the next year compared to the current price of 1.93.
The average price target has been revised upward by 25% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

CUR Current Analyst RatingCUR Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

CUR Historical Analyst RatingsCUR Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
84.00%
CUR.CA was analyzed by 10 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about CUR.CA.
In the previous month the buy percentage consensus was at a similar level.
CUR.CA was analyzed by 10 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

Full Analyst Estimates 2023 - 2024

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2016 2017 2018 2019 2020 2021 2022 2023 2024
Revenue
YoY % growth
CUR.CA revenue by date.CUR.CA revenue by date.
N/AN/A
EBITDA
YoY % growth
CUR.CA ebitda by date.CUR.CA ebitda by date.
N/A-1.952M-1.925M
1.41%
-1.38M
28.30%
-2.712M
-96.51%
-70.743M
-2,508.94%
-25.773M
63.57%
N/AN/A
EBIT
YoY % growth
CUR.CA ebit by date.CUR.CA ebit by date.
-260.73K-1.958M
-650.96%
-1.936M
1.13%
-1.423M
26.52%
-2.74M
-92.59%
-70.788M
-2,483.74%
-25.842M
63.49%
N/AN/A
Operating Margin
CUR.CA operating margin by date.CUR.CA operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
CUR.CA eps by date.CUR.CA eps by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/A
58.33%

All data in CAD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in CAD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CUR.CA Yearly EPS VS EstimatesCUR.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 -0.1 -0.2 -0.3 -0.4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

CONSOLIDATED URANIUM INC / CUR.CA Forecast FAQ

Can you provide the average price target for CONSOLIDATED URANIUM INC stock?

10 analysts have analysed CUR.CA and the average price target is 5.1 CAD. This implies a price increase of 164.25% is expected in the next year compared to the current price of 1.93.

What is the consensus rating for CONSOLIDATED URANIUM INC (CUR.CA) stock?

The consensus rating for CONSOLIDATED URANIUM INC (CUR.CA) is 84 / 100 . This indicates that analysts generally have a positive outlook on the stock.